Poseida Therapeutics' Series A Round

Poseida Therapeutics raised a round of funding on December 16, 2015. Investors include Malin Corporation.

Poseida Therapeutics is translating gene editing technologies into lifesaving treatments. The company is developing CAR T-cell immunotherapies for multiple myeloma and other cancer types, as well as g…

Articles about Poseida Therapeutics' Series A Round: